NovaBay Pharmaceuticals Inc (NBY) — Strategic Asset Allocation Index
NovaBay Pharmaceuticals Inc (NBY) has a Strategic Asset Allocation Index of 11.9% as of September 2025. Strategic assets (PP&E of $195.00K plus long-term investments of $-) total $195.00K, measured against net assets of $1.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See NovaBay Pharmaceuticals Inc (NBY) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
NovaBay Pharmaceuticals Inc Strategic Asset Allocation Index (2005–2023)
This chart shows how NovaBay Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2023. As of September 2025, the index stands at 11.9%, representing strategic assets of $195.00K against net assets of $1.63 Million USD. For live market cap and overall valuation, see market value of NovaBay Pharmaceuticals Inc.
Annual Strategic Asset Allocation Index for NovaBay Pharmaceuticals Inc (2005–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for NovaBay Pharmaceuticals Inc from 2005 to 2023, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See NovaBay Pharmaceuticals Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 41.7% | $1.38 Million | $1.38 Million | $- | $3.31 Million | ▲ +23.3 pp |
| 2022 | 18.5% | $1.95 Million | $1.95 Million | $- | $10.55 Million | ▲ +12.5 pp |
| 2021 | 5.9% | $604.00K | $604.00K | $- | $10.17 Million | ▲ +1.7 pp |
| 2020 | 4.2% | $520.00K | $520.00K | $- | $12.32 Million | ▼ -7.1 pp |
| 2019 | 11.3% | $110.00K | $110.00K | $- | $973.00K | ▲ +7.2 pp |
| 2018 | 4.1% | $201.00K | $201.00K | $- | $4.95 Million | ▼ -14.1 pp |
| 2017 | 18.2% | $471.00K | $471.00K | $- | $2.59 Million | ▲ +12.9 pp |
| 2016 | 5.2% | $371.00K | $371.00K | $- | $7.10 Million | ▼ -18.4 pp |
| 2014 | 23.6% | $436.00K | $436.00K | $- | $1.85 Million | ▲ +15.2 pp |
| 2013 | 8.4% | $718.00K | $718.00K | $- | $8.52 Million | ▲ +2.1 pp |
| 2012 | 6.3% | $891.00K | $891.00K | $- | $14.05 Million | ▼ -7.2 pp |
| 2011 | 13.6% | $1.27 Million | $1.27 Million | $- | $9.34 Million | ▼ -1.5 pp |
| 2010 | 15.1% | $1.59 Million | $1.59 Million | $- | $10.49 Million | ▲ +1.6 pp |
| 2009 | 13.6% | $1.81 Million | $1.81 Million | $- | $13.35 Million | ▼ -6.2 pp |
| 2008 | 19.8% | $1.46 Million | $1.46 Million | $- | $7.34 Million | ▲ +11.8 pp |
| 2007 | 8.0% | $1.15 Million | $1.15 Million | $- | $14.32 Million | ▼ -22.5 pp |
| 2006 | 30.6% | $554.00K | $554.00K | $- | $1.81 Million | ▲ +22.3 pp |
| 2005 | 8.2% | $267.00K | $267.00K | $- | $3.25 Million | — |